Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

However, the frequency of your nightmares, and how old you are when you experience them, might reveal information about your ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box ...

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

People may also refer to DLB as Lewy body dementia (LBD), but DLB is just one type of LBD. Parkinson’s disease dementia (discussed below) is the other type. People with DLB may also: experience ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

The average Montreal Cognitive Assessment (MoCA) score at screening was 19 in both groups, indicating mild to moderate ...

Treatments targeting alpha-synuclein aggregation account for 26% of the 7MM' pipeline disease-modifying therapies for ...

Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...